No Data
No Data
Investors Don't See Light At End Of Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) Tunnel And Push Stock Down 28%
Changyao Holdings: 2024 Semi-Annual Report Summary
Changyao Holdings: 2024 Semi-Annual Report
Changjiang Pharmaceutical Group (300391.SZ) has released its first-half performance, with a net loss of 0.153 billion yuan, an increase of 530.08%.
Changjiang Pharmaceutical Group (300391.SZ) released the 2024 interim report, and the company's revenue was 7365....
Changjiang Pharmaceutical Group (300391.SZ): The net loss in the first half of the year was 0.153 billion yuan.
Changjiang Pharmaceutical Group (300391.SZ) announced its 2024 semi-annual report, with revenue for the reporting period of 73.6537 million yuan, a year-on-year decrease of 84.53%; net income attributable to shareholders of listed companies was -0.153 billion yuan, with a widened year-on-year loss; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was -0.15 billion yuan; basic earnings per share was -0.4355 yuan.
Changjiang Pharmaceutical Group Co., Ltd.'s (SZSE:300391) 129% Share Price Surge Not Quite Adding Up
Changjiang Pharmaceutical Group Co., Ltd. (SZSE:300391) Surges 52% Yet Its Low P/S Is No Reason For ExcitementNo Data
